HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goldstein, D. J. Articles by Oz, M. C. Search for Related Content PubMed PubMed Citation Articles by Goldstein, D. J. Articles by Oz, M. C.

Ann Thorac Surg 1995;59:1063-1068
© 1995 The Society of Thoracic Surgeons

---

Articles

Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality

Divisions of Cardiothoracic Surgery and Circulatory Physiology, College of Physicians & Surgeons, Columbia University, New York, New York, USA

^* Address reprint requests to Dr Oz, Division of Cardiothoracic Surgery, Columbia Presbyterian Medical Center, Milstein Hospital 7GN-435, New York, NY 10032.

	Abstract

Top Abstract Footnotes References

 
Aprotinin, a bovine protease inhibitor, has been used extensively in patients undergoing cardiac surgical procedures in an effort to minimize blood loss and prevent the complications associated with blood replacement. We sought to evaluate the effect of aprotinin on postoperative blood loss, renal function, and the incidence of right ventricular failure in patients undergoing placement of a TCI Heartmate left ventricular assist device as a bridge to cardiac transplantation. Retrospective data analysis in 142 patients (42 receiving aprotinin and 100 untreated) demonstrated that the use of aprotinin was associated with a significant decrease in postoperative blood loss (p = 0.019) and in the intraoperative packed red blood cell transfusion (p = 0.019) and total blood product (p = 0.016) requirements. A transient, yet significant, increase in the postoperative creatinine level in the aprotinin group (p = 0.0006), but not in blood urea nitrogen level (p = 0.22), was noted. Interestingly, we noted an association between blood loss and the subsequent development of right ventricular failure; patients who required a right ventricular assist device bled significantly more than did those who did not suffer right ventricular failure (p = 0.02). Additionally, aprotinin recipients benefited by a reduction of nearly one half in the incidence of the need for a right ventricular assist device. The incidence of perioperative mortality was reduced in those receiving aprotinin compared with that in untreated and patients, (p = 0.05). We conclude that aprotinin is safe and effective in decreasing postoperative blood loss and intraoperative blood product requirements, and in reducing perioperative mortality in patients undergoing left ventricular assist device placement as a bridge to cardiac transplantation.

	Footnotes

Top Abstract Footnotes References

 
Presented at the Thirty-first Annual Meeting of The Society of Thoracic Surgeons, Palm Springs, CA, Jan 31–Feb 2, 1995.

	References

Top Abstract Footnotes References

 

1. McBride L. Bridging to cardiac transplantation with external ventricular assist devices Semin Thorac Cardiovasc Surg 1994;6:169-173.[Medline]
2. McCarthy PM, Sabik JF. Implantable circulatory support devices as a bridge to heart transplantation Semin Thorac Cardiovasc Surg 1994;6:174-180.[Medline]
3. Tanaka K, Wada K, Morimoto T, et al. Hemostatic alterations caused by ventricular assist devices for postcardiotomy heart failure Artif Organs 1991;15:59-65.[Medline]
4. Cryer HG, Mavroudis C, Yu J, et al. Shock, transfusion and pneumonectomy: death is due to right heart failure and increased pulmonary vascular resistance Ann Surg 1990;212:197-201.[Medline]
5. Shenkar R, Coulson WF, Abraham E. Hemorrhage and resuscitation induce alterations in cytokine expression and the development of acute lung injury Am J Respir Cell Mol Biol 1994;10:290-297.[Abstract/Free Full Text]
6. Bidstrup BP, Royston D, Sapsford RN, Taylor KM. Reduction in blood loss and blood use after cardiopulmonary bypass with high-dose aprotinin J Thorac Cardiovasc Surg 1989;97:364-372.[Abstract]
7. Bidstrup BP, Harrison J, Royston D, Taylor KM, Treasure T. Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centers in the United Kingdom Ann Thorac Surg 1993;55:971-976.[Abstract/Free Full Text]
8. Havel M, Teufelsbauer H, Knobl P, et al. Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operations J Thorac Cardiovasc Surg 1991;101:968-972.[Abstract]
9. Dietrich W, Barankay A, Dilthey G, et al. Reduction of homologous blood requirement in cardiac surgery by intraoperative aprotinin application: clinical experience in 152 cardiac surgical patients Thorac Cardiovasc Surg 1989;37:92-98.[Medline]
10. Lemmer JH, Stanford W, Bonney SL, et al. Aprotinin for coronary bypass operations: efficacy, safety and influence on early saphenous vein graft patency J Thorac Cardiovasc Surg 1994;107:543-553.[Abstract/Free Full Text]
11. Schulz K, Graeter T, Schaps D, Hausen B. Severe anaphylactic shock due to repeated application of aprotinin in patients following intrathoracic aortic replacement Eur J Cardiothorac Surg 1993;7:495-496.[Abstract/Free Full Text]
12. Levy JH. Antibody formation after drug administration during cardiac surgery: parameters for aprotinin use J Heart Lung Transplant 1993;12:S26-S33.[Medline]
13. Cosgrove III DM, Heric B, Lytle BW, et al. Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study Ann Thorac Surg 1992;54:1031-1038.[Abstract/Free Full Text]
14. Fuhrer F, Gallimore MJ, Heller W, Hoffmeister HE. Aprotinin in cardiopulmonary bypass: effects on the Hageman factor (FXII)—Kallikrein system and blood loss Blood Coagul Fibrinolysis 1992;3:99-104.[Medline]
15. Van Oeveren W, Harder MP, Roozendaal KJ, Eijsman L, Wildevuur CRH. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass J Thorac Cardiovasc Surg 1990;99:788-797.[Abstract]
16. Blauhut B, Gross C, Necek S, Doran JE, Spath P, Lundsgaard-Hansen P. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement and renal function after cardiopulmonary bypass J Thorac Cardiovasc Surg 1991;101:958-967.[Abstract]
17. [Abstract]Pae WE, Aufiero TX, Weldner PW, Miller CA, Pierce WS. Aprotinin therapy for insertion of ventricular assist devices for staged cardiac transplantation J Heart Lung Transplant 1994:S56.
18. Seto S, Kher V, Scicli AG, Beierwaltes WH, Carretero OA. The effect of aprotinin (a serine protease inhibitor) on renal function and renin release Hypertension 1983;5:893-899.[Abstract/Free Full Text]
19. Rustom R, Jackson MJ, Critchley M, Bone JM. Tubular metabolism of aprotinin 99m Tc and urinary ammonia: effects of proteinuria Miner Electrolyte Metab 1992;18:108-112.[Medline]
20. Hunt E, Moore JB. Use of blood and blood products Vet Clin North Am 1990;6:133-147.
21. Hegewisch S, Weh HJ, Hossfeld DK. TNF-induced cardiomyopathy Lancet 1990;335:294-295.[Medline]
22. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of TNF in severe chronic heart failure N Engl J Med 1990;323:236-241.[Medline]
23. Mann DL, Young JB. Basic mechanisms in congestive heart failure Recognizing the role of proinflammatory cytokines Chest 1994;105:897-904.[Medline]
24. Havel MP, Griescmacher A, Weigel G, et al. Aprotinin decreases release of 6-keto-prostaglandin F1a and increases release of thromboxane B2 in cultured human umbilical vein endothelial cells J Thorac Cardiovasc Surg 1992;104:654-658.[Abstract]
25. Cave AC, Manche A, Derias NW, Hearse DJ. Thromboxane A2 mediates pulmonary hypertension after cardiopulmonary bypass in the rabbit J Thorac Cardiovasc Surg 1993;106:959-967.[Abstract]

This article has been cited by other articles:

				R. L. Kormos, J. J. Teuteberg, F. D. Pagani, S. D. Russell, R. John, L. W. Miller, T. Massey, C. A. Milano, N. Moazami, K. S. Sundareswaran, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes J. Thorac. Cardiovasc. Surg., May 1, 2010; 139(5): 1316 - 1324. [Abstract] [Full Text] [PDF]

				S. F. Marasco, D. Pilcher, T. Oto, W. Chang, A. Griffiths, V. Pellegrino, J. Chan, and M. Bailey Aprotinin in lung transplantation is associated with an increased incidence of primary graft dysfunction Eur J Cardiothorac Surg, February 1, 2010; 37(2): 420 - 425. [Abstract] [Full Text] [PDF]

				J. C. Matthews, F. D. Pagani, J. W. Haft, T. M. Koelling, D. C. Naftel, and K. D. Aaronson Model for End-Stage Liver Disease Score Predicts Left Ventricular Assist Device Operative Transfusion Requirements, Morbidity, and Mortality Circulation, January 19, 2010; 121(2): 214 - 220. [Abstract] [Full Text] [PDF]

				S. Osaki, N. M. Edwards, M. Velez, M. R. Johnson, M. A. Murray, J. A. Hoffmann, and T. Kohmoto Improved survival in patients with ventricular assist device therapy: the University of Wisconsin experience Eur J Cardiothorac Surg, August 1, 2008; 34(2): 281 - 288. [Abstract] [Full Text] [PDF]

				I. Apostolidou, M. F. Sweeney, E. Missov, L. D. Joyce, R. John, and R. C. Prielipp Acute Left Atrial Thrombus After Recombinant Factor VIIa Administration During Left Ventricular Assist Device Implantation in a Patient with Heparin-Induced Thrombocytopenia Anesth. Analg., February 1, 2008; 106(2): 404 - 408. [Abstract] [Full Text] [PDF]

				I. George and M. C. Oz Myocardial Revascularization after Acute Myocardial Infarction , January 1, 2008; 3(2008): 669 - 696. [Full Text]

				S. Aggarwal, F. Cheema, M. C. Oz, and Y. Naka Long-Term Mechanical Circulatory Support , January 1, 2008; 3(2008): 1609 - 1628. [Full Text]

				J. N. Schroder, M. A. Daneshmand, N. R. Villamizar, R. P. Petersen, L. J. Blue, I. J. Welsby, A. J. Lodge, T. L. Ortel, J. G. Rogers, and C. A. Milano Heparin-Induced Thrombocytopenia in Left Ventricular Assist Device Bridge-to-Transplant Patients Ann. Thorac. Surg., September 1, 2007; 84(3): 841 - 846. [Abstract] [Full Text] [PDF]

				S. G. Drakos, J. C. Stringham, J. W. Long, E. M. Gilbert, T. C. Fuller, B. K. Campbell, B. D. Horne, M. E. Hagan, K. E. Nelson, J. M. Lindblom, et al. Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: The impact of leukofiltered cellular blood product transfusions J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1612 - 1619. [Abstract] [Full Text] [PDF]

				L. Santambrogio, T. Bianchi, M. Fuardo, F. Gazzoli, R. Veronesi, A. Braschi, and M. Maurelli Right ventricular failure after left ventricular assist device insertion: preoperative risk factors Interact CardioVasc Thorac Surg, August 1, 2006; 5(4): 379 - 382. [Abstract] [Full Text] [PDF]

				J. R. Cooper Jr, J. Abrams, O.H. Frazier, R. Radovancevic, B. Radovancevic, A. W. Bracey, M. J. Kindo, and I. D. Gregoric Fatal pulmonary microthrombi during surgical therapy for end-stage heart failure: Possible association with antifibrinolytic therapy J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 963 - 968. [Abstract] [Full Text] [PDF]

				J. A. Morgan, R. John, V. Rao, A. D. Weinberg, B. J. Lee, P. A. Mazzeo, M. R. Flannery, J. M. Chen, M. C. Oz, and Y. Naka Bridging to transplant with the HeartMate left ventricular assist device: The Columbia Presbyterian 12-year experience J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1309 - 1316. [Abstract] [Full Text] [PDF]

				D. J. Goldstein and R. B. Beauford Left ventricular assist devices and bleeding: adding insult to injury Ann. Thorac. Surg., June 1, 2003; 75(90060): S42 - 47. [Abstract] [Full Text] [PDF]

				W. E. Richenbacher, Y. Naka, E. P. Raines, O. H. Frazier, G. S. Couper, F. D. Pagani, L. Damme, C. H. VanMeter, G. J. Magovern Jr, L. Gupta, et al. Surgical management of patients in the REMATCH trial Ann. Thorac. Surg., June 1, 2003; 75(90060): S86 - 92. [Abstract] [Full Text] [PDF]

				V. Rao, M. C. Oz, M. A. Flannery, K. A. Catanese, M. Argenziano, and Y. Naka Revised screening scale to predict survival after insertion of a left ventricular assist device J. Thorac. Cardiovasc. Surg., April 1, 2003; 125(4): 855 - 862. [Abstract] [Full Text]

				D. C. Lee, W. Ting, and M. C. Oz Myocardial Revascularization after Acute Myocardial Infarction , January 1, 2003; 2(2003): 639 - 658. [Full Text]

				P. Naughton and C. A. Bashour Mechanical Support After Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2002; 6(3): 237 - 257. [Abstract] [PDF]

				M. P. Siegenthaler, J. Martin, O. H. Frazier, and F. Beyersdorf Implantation of the permanent Jarvik-2000 left-ventricular-assist-device: surgical technique Eur J Cardiothorac Surg, March 1, 2002; 21(3): 546 - 548. [Abstract] [Full Text] [PDF]

				O. H. Frazier, E. A. Rose, M. C. Oz, W. Dembitsky, P. McCarthy, B. Radovancevic, V. L. Poirier, and K. A. Dasse Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation J. Thorac. Cardiovasc. Surg., December 1, 2001; 122(6): 1186 - 1195. [Abstract] [Full Text] [PDF]

				M. A. Bedirhan, A. Turna, N. Yagan, and O. Tasci Aprotinin reduces postoperative bleeding and the need for blood products in thoracic surgery: results of a randomized double-blind study Eur J Cardiothorac Surg, December 1, 2001; 20(6): 1122 - 1127. [Abstract] [Full Text] [PDF]

				J. R Pepper Surgery for heart failure: options and outcomes Perfusion, July 1, 2000; 15(4): 287 - 293. [PDF]

				D. Gagnon, M. Petty, and J. R Lahpor HeartMate(R) family of left ventricular assist systems Perfusion, July 1, 2000; 15(4): 345 - 354. [PDF]

				E. Gronda and E. Vitali Left ventricle assist systems: a possible alternative to heart transplantation for heart failure patients? Patient selection, techniques and benefit Eur J Heart Fail, December 17, 1999; 1(4): 319 - 325. [Full Text] [PDF]

				K. Fukamachi, P. M. McCarthy, N. G. Smedira, R. L. Vargo, R. C. Starling, and J. B. Young Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion Ann. Thorac. Surg., December 1, 1999; 68(6): 2181 - 2184. [Abstract] [Full Text] [PDF]

				D. N. Helman, D. L.S. Morales, N. M. Edwards, D. M. Mancini, J. M. Chen, E. A. Rose, and M. C. Oz Left ventricular assist device bridge-to-transplant network improves survival after failed cardiotomy Ann. Thorac. Surg., October 1, 1999; 68(4): 1187 - 1194. [Abstract] [Full Text] [PDF]

				D. Mavroidis, B. C. Sun, and W. E. Pae Jr Bridge to transplantation: the Penn State experience Ann. Thorac. Surg., August 1, 1999; 68(2): 684 - 687. [Abstract] [Full Text] [PDF]

				B. C. Sun, K. A. Catanese, T. B. Spanier, M. R. Flannery, M. T. Gardocki, L. S. Marcus, H. R. Levin, E. A. Rose, and M. C. Oz 100 long-term implantable left ventricular assist devices: the Columbia Presbyterian interim experience Ann. Thorac. Surg., August 1, 1999; 68(2): 688 - 694. [Abstract] [Full Text] [PDF]

				C. Baufreton, M. Kirsch, and D. Y. Loisance Measures to control blood activation during assisted circulation Ann. Thorac. Surg., November 1, 1998; 66(5): 1837 - 1844. [Abstract] [Full Text] [PDF]

				B. Koul, J.-O. Solem, S. Steen, H. Casimir-Ahn, H. Granfeldt, and U. J. Lonn HeartMate Left Ventricular Assist Device as Bridge to Heart Transplantation Ann. Thorac. Surg., June 1, 1998; 65(6): 1625 - 1630. [Abstract] [Full Text] [PDF]

				J. J. DeRose Jr, J. P. Umana, M. Argenziano, K. A. Catanese, H. R. Levin, B. C. Sun, E. A. Rose, and M. C. Oz Improved Results for Postcardiotomy Cardiogenic Shock With the Use of Implantable Left Ventricular Assist Devices Ann. Thorac. Surg., December 1, 1997; 64(6): 1757 - 1762. [Abstract] [Full Text]

				D. Royston Hemostatic Drugs in Prothrombotic or Hypercoagulable States Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 1997; 1(4): 376 - 394. [Abstract] [PDF]

				MehmetC. Oz, M. Argenziano, K. A. Catanese, M. T. Gardocki, D. J. Goldstein, R. C. Ashton, A. C. Gelijns, E. A. Rose, and H. R. Levin Bridge Experience With Long-term Implantable Left Ventricular Assist Devices: Are They an Alternative to Transplantation? Circulation, April 1, 1997; 95(7): 1844 - 1852. [Abstract] [Full Text]

				A. M. Scheule, M. J. Jurmann, H. P. Wendel, L. Haberle, F. S. Eckstein, and G. Ziemer Anaphylactic Shock After Aprotinin Reexposure: Time Course of Aprotinin-Specific Antibodies Ann. Thorac. Surg., January 1, 1997; 63(1): 242 - 244. [Abstract] [Full Text]

				W. E. Richenbacher and W. S. Pierce Mechanical Circulatory Support Ann. Thorac. Surg., November 1, 1996; 62(5): 1558 - 1559. [Full Text]

				T. W. Prendergast, S. Furukawa, A. J. Beyer III, H. J. Eisen, J. B. McClurken, and V. Jeevanandam Defining the Role of Aprotinin in Heart Transplantation Ann. Thorac. Surg., September 1, 1996; 62(3): 670 - 674. [Abstract] [Full Text]

				L. Martinelli, M. Maurelli, M. Vigano', and M. C. Oz Aprotinin in Staged Heart Transplantation: Anaphylactic Potential of Repeated Exposure Ann. Thorac. Surg., April 1, 1996; 61(4): 1288 - 1289. [Full Text]

				D. J. Goldstein, M. C. Oz, C. R. Smith, J. P. Friedlander, C. M. De Rosa, L. B. Mongero, and E. Delphin Safety of Repeat Aprotinin Administration for LVAD Recipients Undergoing Cardiac Transplantation Ann. Thorac. Surg., February 1, 1996; 61(2): 692 - 695. [Abstract] [Full Text]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goldstein, D. J. Articles by Oz, M. C. Search for Related Content PubMed PubMed Citation Articles by Goldstein, D. J. Articles by Oz, M. C.